We decided to inject plasmatic human FH into the cerebrospinal fluid (CSF) of APP/PS1 mice at two stages of AD development: the early stage (6 months) and the late stage (9 months) (Supplemental Figure S1b,c). Here, FH is linked to Alzheimer disease.